Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E
BackgroundThe dismal efficacy of immunotherapy for Pancreatic cancer (PC) can be predominantly ascribed to its distinctive cold-tumor properties. The by-products of purine metabolic reprogramming are extensively engaged in tumor immune modulation, influencing the functions and recruitment of immune...
Saved in:
| Main Authors: | Junqian Zhang, Xiaobo Zhang, Ruixin Wu, Chang-Sheng Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1569088/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models
by: Zhixiong Cai, et al.
Published: (2025-03-01) -
Synthesis, Antiproliferative Activity, and ADME Profiling of Novel Racemic and Optically Pure Aryl-Substituted Purines and Purine Bioisosteres
by: Martina Piškor, et al.
Published: (2025-02-01) -
Multidimensional transcriptomics based to illuminate the mechanisms of taurine metabolism in immune resistance of pancreatic cancer
by: Zongshuai Qin, et al.
Published: (2025-03-01) -
Purine content of different soybean products and dynamic transfer in food processing techniques
by: Yuting Zheng, et al.
Published: (2025-05-01) -
Purine metabolism state in patients with type 1 diabetes mellitus
by: A. O. Cherniaieva, et al.
Published: (2023-04-01)